Table 5 Compliance by age group in patients with ulcerative colitis, sanitary district of Lleida (Spain) 2016
Infections | ≤ 40 y (n = 377) | 41–60 y (n = 511) | ≥ 61 y (n = 532) | Total (n = 1420) | P value |
|---|---|---|---|---|---|
No. (%) (95% CI) | No. (%) (95% CI) | No. (%) (95% CI) | No. (%) (95% CI) | ||
Measles, mumps, rubella | 60 (15.9%) (12.2–19.6) | 320 (62.6%) (58.3–66.8) | 532 (100%) (99.3–100) | 912 (64.2%) (61.7–66.7) | < 0.001 |
Varicella | 136 (36.1%) (31.2–40.9) | 147 (28.8%) (12.2–19.6) | 52 (9.8%) (7.2–12.3) | 335 (23.6%) (21.4–25.8) | < 0.001 |
Tetanus-diphtheria | 61 (16.2%) (12.5–19.9) | 152 (29.7%) (25.8–33.7) | 178 (33.5%) (29.4–37.5) | 391 (27.5%) (25.2–29.9) | < 0.001 |
Influenza | 1 (0.3%) (0.0–0.8) | 7 (1.4%) (0.4–2.4) | 378 (71.1%) (67.2–74.9) | 386 (27.2%) (24.9–29.5) | < 0.001 |
Pneumococcus | 21 (5.6%) (3.3–7.9) | 36 (7%) (4.8–9.3) | 39 (7.3%) (5.1–9.5) | 96 (6.8%) (5.5–8.1) | 0.316 |
Meningococcus C | 35 (9.3%) (6.4–12.2) | 55 (10.8%) (8.1–13.5%) | 21 (3.9%) (2.3–5.6%) | 111 (7.8%) (6.4–9.2%) | 0.001 |
Hepatitis B | 19 (5%) (2.8–7.2%) | 56 (11%) (8.3–13.7) | 24 (4.5%) (2.7–6.3) | 99 (7%) (5.6–8.3) | 0.445 |
Hepatitis A | 14 (3.7%) (1.8–5.6) | 12 (2.3%) (1.0–3.7) | 1 (0.2%) (0.0–0.6) | 27 (1.9%) (1.2–2.6) | < 0.001 |